Plastic surgeons who perform liposuction already access the tissue that adipose banking preserves, which makes them a natural collection partner. The questions are operational: how to divert a portion of lipoaspirate for banking, what consent and chain-of-custody require, and where the relevant state law does and does not apply. This guide walks through the workflow without overstating what banking offers.
TLDR: Liposuction already produces the adipose tissue that banking preserves, so a portion of lipoaspirate can be diverted for storage with the right consent and handling. Banking is preservation of a patient’s own tissue, not a treatment, and it is a separate activity from administering stem cell therapy. Florida SB 1768 governs administering therapy for orthopedics, wound care, and pain management; cosmetic procedures fall outside that therapeutic scope, and the statute does not authorize any cosmetic or therapeutic use of banked tissue. No adipose-derived product holds FDA approval for any therapeutic indication. Banking operates under 21 CFR Part 1271 and guarantees no eligibility, access, or clinical benefit.
Important Disclaimer: Save My Fat does not provide FDA-approved treatments or cures for any disease or condition. No adipose-derived stem cell product currently has FDA approval for any therapeutic indication. Banking adipose tissue today does not guarantee eligibility, access, or clinical benefit from any future therapy, clinical trial, or medical program. All content is for educational purposes only and does not constitute medical advice. Patients must consult their own licensed healthcare professionals regarding all medical decisions.
For a plastic surgery practice, integrating banking is primarily a matter of workflow and consent, because the tissue is already being collected. The sections below cover why the fit is natural, the scope limitation to keep in view, and the operational steps from diversion to transfer.
Why Plastic Surgeons Are the Natural Banking Partner
Liposuction generates lipoaspirate, the same adipose tissue that a banking service preserves, which is why plastic surgeons are well positioned to offer collection. Rather than treating all lipoaspirate as surgical waste, a practice can divert a portion for banking when a patient elects it. The collection step is therefore an extension of a procedure the surgeon already performs.
It is worth stating the boundary at the outset. Offering banking means offering preservation of a patient’s own tissue, not administering any therapy. The overview of why physicians add banking describes the service model, which is collection, transfer, and long-term storage, with no treatment component.
The Scope Limitation Plastic Surgeons Must Understand
The relevant state law has a scope that plastic surgeons should understand precisely. Florida Statutes Section 458.3245, effective July 1, 2025, permits physicians to administer non-FDA-approved stem cell therapy only for orthopedics, wound care, or pain management. Cosmetic procedures are not within that therapeutic scope, and the statute does not authorize any cosmetic or therapeutic use of banked adipose tissue.
Two points follow. First, banking lipoaspirate during a cosmetic procedure is a preservation activity, and it is distinct from the therapy administration the statute regulates. Second, credible legal and industry analyses read the statute as excluding adipose-derived cells as a permitted therapy source even within its named indications, a question any practice exploring therapy should confirm with counsel. For the statute’s provider obligations, the SB 1768 checklist provides detail. The practical message is that banking is offered as preservation, and no claim should connect it to a cosmetic or therapeutic benefit.
Diverting Lipoaspirate: What the Workflow Looks Like
Diverting lipoaspirate for banking is a documented handling step layered onto an existing procedure. When a patient elects banking, a portion of the lipoaspirate is set aside under proper conditions during the liposuction, handled to preserve tissue integrity, and prepared for transfer to the processing and storage partner. The surgeon continues to perform the cosmetic procedure as planned.
The provider-facing overview of the harvest procedure outlines collection, handling, and transfer in detail. The core requirements are sterile technique, appropriate handling of the diverted portion, and accurate documentation of what was collected and when. The purpose throughout is preservation, not preparation of a therapeutic product.
Separate Consent Is Non-Negotiable
Banking requires its own separate, specific informed consent, distinct from the surgical and cosmetic consent the patient has already provided. A patient consenting to liposuction for contouring has not thereby consented to bank tissue, and the two decisions must be documented separately. The banking consent should state that banking is preservation, not treatment, and that it guarantees no future access or benefit.
The requirements for this consent are summarized in the overview of informed consent for tissue banking. A practice should ensure the banking consent is obtained before the procedure, retained with the banking records, and kept distinct from the cosmetic surgical record.
Chain-of-Custody and Transfer to L2 Bio
Once a portion of lipoaspirate is diverted, it must move to processing and storage under a documented chain-of-custody. That means recording the handoff, labeling accurately, and transferring the tissue to the processing and storage partner under conditions that preserve it. Chain-of-custody documentation protects the patient and the practice and is part of operating responsibly under federal tissue regulations.
The overview of L2 Bio processing describes how the partner handles tissue after transfer. The service operates under 21 CFR Part 1271, the federal framework governing screening, handling, and storage of human cells and tissues, and a practice should retain documentation of the partner’s regulatory status.
Banking-Integrated vs. Standard Liposuction: Workflow Table
The table below compares a standard liposuction workflow with a banking-integrated one.
| Step | Standard liposuction | Banking-integrated liposuction |
| Primary purpose | Cosmetic contouring | Cosmetic contouring plus preservation of a tissue portion |
| Consent | Surgical and cosmetic consent | Surgical and cosmetic consent plus separate banking consent |
| Lipoaspirate handling | Discarded as surgical waste | A portion diverted under documented handling |
| Downstream processing | None | Transfer to processing and storage partner under chain-of-custody |
| Regulatory frame | Standard surgical | Adds 21 CFR Part 1271 for the banked tissue |
| Therapy administered | None | None; banking is preservation, not therapy |
The comparison underscores that integration adds documentation and a separate consent, not a treatment step.
Physician Action Checklist
A condensed action list for a plastic surgery practice:
- Confirm that banking is offered as preservation only, with no cosmetic or therapeutic claims attached to banked tissue.
- Implement separate, specific banking consent obtained before the procedure and kept distinct from the cosmetic record.
- Establish a documented diversion and handling step within the existing liposuction workflow.
- Maintain chain-of-custody records for transfer to the processing and storage partner.
- Verify and retain the banking partner’s 21 CFR Part 1271 regulatory status.
Frequently Asked Questions
Can banked lipoaspirate be used for cosmetic or therapeutic purposes under SB 1768?
No. SB 1768 governs administering non-FDA-approved therapy for orthopedics, wound care, and pain management, and cosmetic procedures fall outside that scope. The statute does not authorize any cosmetic or therapeutic use of banked tissue, and banking is offered as preservation only.
Does banking during liposuction add a treatment step?
No. Banking adds a documented diversion, handling, and transfer step for preservation. It does not involve administering any therapy, and no treatment is performed.
Is separate consent really required if the patient already consented to liposuction?
Yes. Consent to liposuction for contouring does not constitute consent to bank tissue. Banking requires its own separate, specific informed consent, documented apart from the cosmetic surgical record.
Is there an FDA-approved adipose stem cell therapy a plastic surgeon can offer?
No. No adipose-derived product holds FDA approval for any therapeutic indication. Banking is preservation of a patient’s own tissue and is not a treatment.
How is the banked tissue regulated after transfer?
Banked adipose tissue is handled under 21 CFR Part 1271, the federal framework governing screening, processing, and storage of human cells and tissues, by the processing and storage partner.
Key Takeaways
For plastic surgeons, banking is a natural extension of liposuction because the tissue is already collected, but the boundaries must stay clear. A portion of lipoaspirate can be diverted for preservation with separate consent and documented handling, and banking is preservation of a patient’s own tissue rather than a treatment or a therapy-administration step. Florida SB 1768 governs administering therapy for orthopedics, wound care, and pain management, cosmetic procedures fall outside that scope, and the statute does not authorize any cosmetic or therapeutic use of banked tissue, with credible analyses also reading adipose-derived cells as excluded from its therapy pathway. No adipose-derived product holds FDA approval for any therapeutic indication, and integration adds chain-of-custody documentation and a partner operating under 21 CFR Part 1271. Above all, banking adipose tissue is a preservation service for potential future use; it is not a treatment, and it does not guarantee eligibility, access, or clinical benefit.
Save My Fat operates as a tissue preservation service, not a medical practice or treatment provider. Stem cell and regenerative medicine regulations vary by state, including specific informed-consent and disclosure requirements in Florida, Utah, and Nevada governing tissue and stem cell services. Banking adipose tissue does not connect patients to any treatment pathway, and any future use depends on FDA regulatory status, physician guidance, and the availability of approved or investigational pathways at that time.
Plastic surgery practices evaluating whether to add a preservation service can review the service model and contact the team to discuss integration and documentation requirements.
Save My Fat partners with L2 Bio for laboratory processing and storage.
This article is for educational purposes only and does not constitute medical or legal advice. Legal and medical review including plastic surgery input is required before publication. Please consult your plastic surgeon before making any decisions about treatment or research participation.
Related guide: the physician resource center.
